IDEXX Laboratories (IDXX) earnings

Earnings (net income) · fiscal 2025
$1.06B

IDEXX Laboratories (IDXX) reported net income of $1.06B in fiscal 2025 (the year ended December 31, 2025). That is 19.3% higher than the $887.87M of fiscal 2024. Figures as of 18 Nov 2026, 09:35 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
$1.06B
Change on fiscal 2024
+19.3%
Growth, 5 years
+12.7% a year
Growth, 10 years
+18.6% a year
Highest on record
$1.06Bfiscal 2025
Lowest on record
$116.17Mfiscal 2008
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

IDEXX Laboratories earnings, in more detail

Over the five fiscal years to 2025 net income grew at a compound 12.7% a year; over ten years the rate was 18.6% a year. Across the 18 fiscal years on record (2008–2025), the highest was $1.06B in fiscal 2025 and the lowest $116.17M in fiscal 2008.

History · 18 fiscal years

Earnings (net income) by fiscal year

IDEXX Laboratories earnings, year by year

IDEXX Laboratories (IDXX) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025$1.06B 19.3% up
2024$887.87M 5.1% up
2023$845.04M 24.4% up
2022$679.09M 8.8% down
2021$744.85M 28.0% up
2020$581.78M 36.0% up
2019$427.72M 13.4% up
2018$377.03M 43.3% up
2017$263.14M 18.5% up
2016$222.05M 15.6% up
2015$192.08M 5.6% up
2014$181.91M 3.1% down
2013$187.80M 5.3% up
2012$178.27M 10.2% up
2011$161.79M 14.5% up
2010$141.28M 15.6% up
2009$122.23M 5.2% up
2008$116.17M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of IDEXX Laboratories and comparable companies
CompanyEarnings (net income)Fiscal year
argenx ARGX$1.29B2025
Edwards Lifesciences EW$1.07B2025
Becton, Dickinson BDX$1.68B2025
IDEXX Laboratories IDXX$1.06B2025
Medline MDLN$1.16B2025
Humana HUM$1.19B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on IDXX

IDEXX Laboratories, figure by figure

IDEXX Laboratories (IDXX) overview: price, valuation and scorecardAll health care companies by market value

IDEXX Laboratories earnings: questions and answers

What is IDEXX Laboratories's net income?

IDEXX Laboratories (IDXX) reported net income of $1.06B in fiscal 2025 (the year ended December 31, 2025). That is 19.3% higher than the $887.87M of fiscal 2024.

What is the growth rate of IDEXX Laboratories's net income?

Over the five fiscal years to 2025 net income grew at a compound 12.7% a year; over ten years the rate was 18.6% a year.

What are the highest and lowest net income figures on record for IDEXX Laboratories?

Across the 18 fiscal years on record (2008–2025), the highest was $1.06B in fiscal 2025 and the lowest $116.17M in fiscal 2008.

How is IDEXX Laboratories's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement. For IDEXX Laboratories it is on record here for 18 fiscal years, 2008 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “IDEXX Laboratories (IDXX) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/IDXX/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.